CD8A and glioblastoma: Together such data strongly support that GBM is mostly associated with protumoural and immunosuppressive cells and consequently may not be a good target for checkpoint inhibitor alone.38 Many addition works are required to determine if elimination of immunosuppressive cells improve outcome or favour infiltration by CD8 T cells and checkpoint efficacy.